Wells Fargo Downgrades Myriad Genetics (MYGN) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 5.82 +0.06 (1.04%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.76 | 52 Week High | $45.34 | |||
| Open | $5.72 | 52 Week Low | $15.92 | |||
| Day High | $5.86 | P/E | 2.50 | |||
| Day Low | $5.60 | EPS | $2.33 | |||
| Volume | 2,099,658 | |||||
